Company Filing History:
1 out of 44 
1 out of 489 
Years Active: 2009
Title: Kristin Strumane: Innovator in Tumor Progression Control
Introduction
Kristin Strumane is a notable inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the area of cancer research. Her innovative work focuses on methods to control tumor progression and invasiveness.
Latest Patents
Kristin holds a patent for a method to control tumor progression and invasiveness. This patent describes a method of modulating E-cadherin mediated cell adhesion. More specifically, it details the use of hECRep1a and homologues thereof to modulate and/or control tumor cell invasiveness. This groundbreaking work has the potential to impact cancer treatment strategies significantly.
Career Highlights
Throughout her career, Kristin has worked with esteemed institutions such as Vlaams Interuniversitair Instituut Voor Biotechnologie and Universiteit Gent. Her experience in these organizations has allowed her to develop her expertise in biotechnology and cancer research.
Collaborations
Kristin has collaborated with notable colleagues, including Frans Van Roy and Geert Berx. These partnerships have further enriched her research and contributed to her innovative approaches in the field.
Conclusion
Kristin Strumane is a pioneering inventor whose work in tumor progression control showcases her dedication to advancing cancer research. Her contributions are vital in the ongoing fight against cancer, and her innovative methods hold promise for future therapeutic developments.